Frontiers in Endocrinology
Mortality and cardiovascular risk of triglyceride-glucose and derived indices in cardiovascular-kidney-metabolic syndrome stages 0-3: a dose-response meta-analysis

Meta-analysis of observational studiesBiomarkers
Dose-response, preregistered CRD420251111362, declared no competing interests
- Cardiovascular-kidney-metabolic syndrome
- Cardiovascular disease
- Cardiovascular disease incidence
- Coronary heart disease
- Heart failure
- Humans
The paper
Beijing University of Chinese Medicine
Frontiers in Endocrinology, 17 Aug 2026

